| Cutting edge: activation of STING in T cells induces type I IFN responses and cell death B Larkin, V Ilyukha, M Sorokin, A Buzdin, E Vannier, A Poltorak The Journal of Immunology 199 (2), 397-402, 2017 | 283 | 2017 |
| Genetics and epigenetics of aging and longevity A Moskalev, A Aliper, Z Smit-McBride, A Buzdin, A Zhavoronkov Cell Cycle 13 (7), 1063-1077, 2014 | 214 | 2014 |
| Retroelements and their impact on genome evolution and functioning E Gogvadze, A Buzdin Cellular and molecular life sciences 66, 3727-3742, 2009 | 168 | 2009 |
| Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis J Sarhan, BC Liu, HI Muendlein, CG Weindel, I Smirnova, AY Tang, ... Cell Death & Differentiation 26 (2), 332-347, 2019 | 162 | 2019 |
| FDA-approved and emerging next generation predictive biomarkers for immune checkpoint inhibitors in cancer patients Y Wang, Z Tong, W Zhang, W Zhang, A Buzdin, X Mu, Q Yan, X Zhao, ... Frontiers in oncology 11, 683419, 2021 | 139 | 2021 |
| In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development IV Ozerov, KV Lezhnina, E Izumchenko, AV Artemov, S Medintsev, ... Nature communications 7 (1), 13427, 2016 | 139 | 2016 |
| A role for G‐CSF and GM‐CSF in nonmyeloid cancers AM Aliper, VP Frieden‐Korovkina, A Buzdin, SA Roumiantsev, ... Cancer medicine 3 (4), 737-746, 2014 | 131 | 2014 |
| The human genome contains many types of chimeric retrogenes generated through in vivo RNA recombination A Buzdin, E Gogvadze, E Kovalskaya, P Volchkov, S Ustyugova, ... Nucleic acids research 31 (15), 4385-4390, 2003 | 128 | 2003 |
| At least 50% of human-specific HERV-K (HML-2) long terminal repeats serve in vivo as active promoters for host nonrepetitive DNA transcription A Buzdin, E Kovalskaya-Alexandrova, E Gogvadze, E Sverdlov Journal of virology 80 (21), 10752-10762, 2006 | 127 | 2006 |
| A new family of chimeric retrotranscripts formed by a full copy of U6 small nuclear RNA fused to the 3′ terminus of l1 A Buzdin, S Ustyugova, E Gogvadze, T Vinogradova, Y Lebedev, ... Genomics 80 (4), 402-406, 2002 | 123 | 2002 |
| Molecular functions of human endogenous retroviruses in health and disease M Suntsova, A Garazha, A Ivanova, D Kaminsky, A Zhavoronkov, ... Cellular and Molecular Life Sciences 72, 3653-3675, 2015 | 104 | 2015 |
| Human-specific subfamilies of HERV-K (HML-2) long terminal repeats: three master genes were active simultaneously during branching of hominoid lineages A Buzdin, S Ustyugova, K Khodosevich, I Mamedov, Y Lebedev, ... Genomics 81 (2), 149-156, 2003 | 101 | 2003 |
| Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH M Suntsova, EV Gogvadze, S Salozhin, N Gaifullin, F Eroshkin, ... Proceedings of the National Academy of Sciences 110 (48), 19472-19477, 2013 | 100 | 2013 |
| Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data AA Buzdin, AA Zhavoronkov, MB Korzinkin, LS Venkova, AA Zenin, ... Frontiers in genetics 5, 55, 2014 | 99 | 2014 |
| Atlas of RNA sequencing profiles for normal human tissues M Suntsova, N Gaifullin, D Allina, A Reshetun, X Li, L Mendeleeva, ... Scientific data 6 (1), 36, 2019 | 97 | 2019 |
| Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells AM Aliper, AB Csoka, A Buzdin, T Jetka, S Roumiantsev, A Moskalev, ... Aging (Albany NY) 7 (1), 26, 2015 | 90 | 2015 |
| Molecular pathway activation–new type of biomarkers for tumor morphology and personalized selection of target drugs A Buzdin, M Sorokin, A Garazha, M Sekacheva, E Kim, N Zhukov, Y Wang, ... Seminars in cancer biology 53, 110-124, 2018 | 79 | 2018 |
| H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 histone tags suggest distinct regulatory evolution of open and condensed chromatin landmarks AA Igolkina, A Zinkevich, KO Karandasheva, AA Popov, MV Selifanova, ... Cells 8 (9), 1034, 2019 | 78 | 2019 |
| Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling PV Spirin, TD Lebedev, NN Orlova, AS Gornostaeva, MM Prokofjeva, ... Leukemia 28 (11), 2222-2228, 2014 | 78 | 2014 |
| Signaling pathways activation profiles make better markers of cancer than expression of individual genes NM Borisov, NV Terekhanova, AM Aliper, LS Venkova, PY Smirnov, ... Oncotarget 5 (20), 10198, 2014 | 78 | 2014 |
Max SorokinOncobox在 oncobox.com 的电子邮件经过验证
